4-(2,6-di-tert-butyl-4-((2-((3,5-di-tert-butyl-4-hydroxyphenyl)thio)propan-2-yl)thio)phenoxy)-4-oxobutanoic acid, 98%, 100mg

2-BROMOPROPIONIC ACID, = 99% (GC), 250g

3,6-Difluoro-pyridazine, 95.0%, 5g

2,3-Dichloropyridine>98.0%(GC)5g

3-Cyclohexylpropionic acid, 95.0%, 5g

TEMPO, min. 98 %, zur Synthese, 5 g, Glasverpackung

Ethyl 2-cyclohexylideneacetate, 95.0%, 10g

(5aR,10bS)-2-(2,4,6-Triisopropylphenyl)-4,5a,6,10b-tetrahydroindeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium tetrafluoroborate, 1g

3-Fluoro-2-iodoaniline, 95.0%, 250mg

dl-2,5-Difluorophenylalanine, 97.0%, 10g

4-Pyridin-3-ylphenol, 95+%, 250mg

N-methyl-1-(3-methyl-5-isoxazolyl)methanamine hydrochloride, 95.0%, 1g

tert-Butyl 4-amino-3-ethoxybenzoate, 98%, 5g